WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-04 10:05 am Purchase |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
WELLINGTON MANAGEMENT CO LLP | 4,814,400 10.700% |
4,814,400 (New Position) |
Filing |